Pioneering Rare Disease Clinical Trials

Recruitment for rare disease clinical trials often requires cross-border strategies and multi-site coordination, making strong project and clinical trial site management essential.

As a global rare disease CRO, Ergomed specializes in locating hard-to-find patients worldwide. Our teams operate across time zones and geographies, providing seamless clinical research support tailored to sponsor needs.

We are recognized as a trusted clinical research organization in rare diseases, with 70% of our Project Managers and 80% of our Clinical Research Associates (CRAs) bringing hands-on experience in rare indications. This expertise allows us to manage even the most complex programs — from clinical site management and study physician support to global patient engagement.

Nearly half of all rare disease patients are children or adolescents, making pediatric trial expertise essential.

As a specialized CRO for rare disease programs, Ergomed has developed a unique family-centric approach that addresses the needs of young patients while recognizing the critical role of their families in care. Our philosophy emphasizes the positive impact on patients’ quality of life, offering reassurance and support throughout the trial journey.

Backed by the expertise of our dedicated Patient Engagement Team, we ensure that children and families remain at the center of every rare disease clinical trial we manage.

Drug development in rare diseases often involves advanced therapy medicinal products, including cell and gene therapy products.

These therapies introduce additional layers of complexity and challenges in clinical trials. We collaborate with physicians to design studies and develop operational strategies that support complex clinical trials. Ergomed’s site management model, combined with our extensive experience in rare disease trials, enables us to effectively recruit patients, maintain a secure chain of custody for treatments and sample collections, ensure close safety monitoring, and collect high-quality data.

At Ergomed, our mission as a leading rare disease CRO is to pioneer innovative rare disease clinical research solutions. With global reach, expert teams, and a patient-first mindset, we are uniquely positioned to navigate the complexities of rare disease clinical trials.

Our role as a trusted clinical research organization extends beyond trial execution: we provide strategic guidance, operational excellence, and compassionate care to advance rare therapies. Through our robust project management and comprehensive clinical research support, Ergomed delivers results that improve lives and create lasting impact in rare disease research.

Join us in shaping the future of healthcare — together we can transform the landscape of rare disease clinical trials.